RetinalGenix Technologies Inc. Files Q1 2025 10-Q
Ticker: RTGN · Form: 10-Q · Filed: May 15, 2025 · CIK: 1836295
| Field | Detail |
|---|---|
| Company | Retinalgenix Technologies Inc. (RTGN) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-instruments
TL;DR
RetinalGenix Q1 2025 10-Q filed. Financials and operations update.
AI Summary
RetinalGenix Technologies Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. The company is incorporated in Delaware and its fiscal year ends on December 31st. Its principal business address is in Petaluma, California.
Why It Matters
This 10-Q filing provides investors with a quarterly update on RetinalGenix Technologies Inc.'s financial health and operational performance, crucial for investment decisions.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain immediate, high-impact news.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of 2025 financial results are detailed.)
- 1231 — Fiscal Year End (Indicates the end of the company's annual accounting cycle.)
Key Players & Entities
- RetinalGenix Technologies Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
- Petaluma, CA (location) — Business address
FAQ
What is the primary business of RetinalGenix Technologies Inc.?
The filing lists the Standard Industrial Classification as 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]', suggesting a focus on medical devices.
When was this 10-Q report filed?
The report was filed on May 15, 2025.
What period does this 10-Q cover?
This 10-Q covers the period ending March 31, 2025.
Where is RetinalGenix Technologies Inc. located?
The company's business address is 1450 North McDowell Boulevard, Suite 150, Petaluma, CA 94954.
What is the SEC file number for RetinalGenix Technologies Inc.?
The SEC file number is 333-258528.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding RetinalGenix Technologies Inc. (RTGN).